help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published as Biophys J. BioFAST on August 17, 2007.
doi:10.1529/biophysj.107.104075
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplement
Right arrow All Versions of this Article:
biophysj.107.104075v1
93/11/4018    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayakawa, E.
Right arrow Articles by Dvorak, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayakawa, E.
Right arrow Articles by Dvorak, J. A.
Biophysical Journal 93:4018-4030 (2007)
© 2007 The Biophysical Society

A Mycobacterium tuberculosis-Derived Lipid Inhibits Membrane Fusion by Modulating Lipid Membrane Domains

Eri Hayakawa * {dagger}, Fuyuki Tokumasu {dagger}, Glenn A. Nardone {ddagger}, Albert J. Jin §, Vince A. Hackley ¶ and James A. Dvorak {dagger}

* Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, 4-1-8, Honcho, Kawaguchi, Saitama, 332-0012, Japan; {dagger} Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases; {ddagger} Research Technology Branch, National Institute of Allergy and Infectious Diseases; and § Division of Bioengineering and Physical Science, ORS/OD, National Institutes of Health, Bethesda, Maryland 20892-5766; and Materials Science and Engineering Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland 20899-8520

Correspondence: Address reprint requests to Fuyuki Tokumasu, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Room 2W-09B Twinbrook III, 12735 Twinbrook Parkway, Bethesda, MD 20892-8132. Tel.: 301-451-1224; Fax: 301-480-1438; E-mail: ftokumasu{at}niaid.nih.gov.

Tuberculosis is an infectious and potentially fatal disease caused by the acid-fast bacillus Mycobacterium tuberculosis (MTB). One hallmark of a tuberculosis infection is the ability of the bacterium to subvert the normal macrophage defense mechanism of the host immune response. Lipoarabinomannan (LAM), an integral component of the MTB cell wall, is released when MTBs are taken into phagosomes and has been reported to be involved in the inhibition of phago-lysosomal (P-L) fusion. However, the physical chemistry of the effects of LAM on lipid membrane structure relative to P-L fusion has not been studied. We produced membranes in vitro composed of dioleoylphosphatidylcholine, sphingomyelin, and cholesterol to simulate phagosomal lipid membranes and quantified the effects of the addition of LAM to these membranes, using fluorescence resonance energy transfer assays and atomic force microscopy. We found that LAM inhibits vesicle fusion and markedly alters lipid membrane domain morphology and sphingomyelin-chollesterol/dioleoylphosphatidylcholine ratios. These data demonstrate that LAM induces a dramatic reorganization of lipid membranes in vitro and clarifies the role of LAM in the inhibition of P-L fusion and the survival of the MTB within the macrophage.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
A. Welin, M. E. Winberg, H. Abdalla, E. Sarndahl, B. Rasmusson, O. Stendahl, and M. Lerm
Incorporation of Mycobacterium tuberculosis Lipoarabinomannan into Macrophage Membrane Rafts Is a Prerequisite for the Phagosomal Maturation Block
Infect. Immun., July 1, 2008; 76(7): 2882 - 2887.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Biophysical Society.